Gilead on Wednesday revealed its latest C-suite addition, with Bristol-Myers Squibb veteran Johanna Mercier taking on the role of chief commercial officer effective July 1.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,